ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
15 announcements with these filters
Citurgia Biochemicals Limited has scheduled its board meeting for November 14, 2026. The meeting will consider and approve unaudited financial results for the quarter ended September 2026.
Citurgia Biochemicals Limited received approval from the Registrar of Companies to extend its 51st Annual General Meeting deadline. The meeting will now be held by December 31, 2026.
Citurgia Biochemicals Ltd has submitted its quarterly shareholding pattern disclosure as required under Regulation 31(1)(b) of the SEBI Listing Regulations.
Citurgia Biochemicals Ltd submitted its Regulation 74(5) compliance certificate from the RTA for the quarter ended September 30, 2026. This is a standard regulatory disclosure.
Citurgia Biochemicals announced a board meeting on October 6, 2026, to discuss scheduling the 51st Annual General Meeting and approving associated reports.
Citurgia Biochemicals Limited received approval from the Registrar of Companies for a one-month extension to hold its 51st Annual General Meeting by October 31, 2026.
Citurgia Biochemicals submitted the resignation letter of CS Yatendra Kumar, effective 24 July 2026. The filing rectifies a prior omission of the letter under Regulation 30 (LODR).
Citurgia Biochemicals Ltd reported a net loss of ₹0.1 Cr for Q1 FY27.
Citurgia Biochemicals Limited will hold a board meeting on August 12, 2026, to consider and approve standalone unaudited financial results for the quarter ended June 30, 2026.
Company Secretary CS Yatendra Kumar has resigned to pursue other carrier opportunities. The resignation is effective from July 24, 2026.
Citurgia Biochemicals Ltd reported a net loss of ₹0.3 Cr for Q4 FY26.
Citurgia Biochemicals reported its audited standalone financial results for the quarter and year ended March 2026. The company recorded zero revenue and a net loss.
Citurgia Biochemicals Limited filed its Annual Secretarial Compliance Report for FY 2025-26. The report details statutory adherence and procedural observations by practicing company secretaries.
Citurgia Biochemicals Limited appointed Mr. Kashi Nath Jha as Chief Financial Officer effective May 29, 2026. He brings 28 years of experience in finance and accounts.
Citurgia Biochemicals scheduled a board meeting for May 30, 2026, to approve annual audited financial results. The trading window remains closed until 48 hours post-declaration.